Overview
Ophthalmic beta adrenergic blockers are topical glaucoma medications that lower intraocular pressure by reducing aqueous humor production in the ciliary body.
- Ophthalmic beta-adrenergic blockers are topical glaucoma medications that lower intraocular pressure by reducing aqueous humor production in the ciliary body. - Their main purpose is long-term IOP management in open-angle glaucoma and ocular hypertension to reduce risk of optic nerve damage, visual field loss, and irreversible vision loss. - Historically, timolol and related agents were major glaucoma therapies. Prostaglandin analogues are often first-line for many patients now, but beta-blockers remain important as adjuncts or alternatives when appropriate. - Clinical significance in nursing practice: these are eye drops with whole-body beta-blocker risks. A patient can develop bradycardia, bronchospasm, hypotension, fatigue, depression, or masked hypoglycemia from ophthalmic therapy. On the exam, writers often pair stable-sounding options with unstable data—notice the mismatch before you commit. If the stem names a license or role, reread that line; scope errors are classic trap answers even when the clinical topic is familiar. Run a 60-second scan: breathing work and oxygenation, perfusion and end organs, neuro baseline, likely infection sources, and devices that can fail quietly. When two answers feel partly right, pick the one that...
